Cargando…
Vascular Ehlers–Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
Autores principales: | Gorosabel, Maria C, Dubacher, Nicolo, Meienberg, Janine, Matyas, Gabor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225867/ https://www.ncbi.nlm.nih.gov/pubmed/31693161 http://dx.doi.org/10.1093/ehjcvp/pvz067 |
Ejemplares similares
-
Improvement in Quality of Life Following Celiprolol Hydrochloride Administration in a Patient with Vascular Ehlers–Danlos Syndrome: A Case Report
por: Shimizu, Kanichiro, et al.
Publicado: (2023) -
Ehlers-Danlos syndrome
por: Taj, Farhana Tahseen, et al.
Publicado: (2014) -
Vascular Ehlers-Danlos syndrome with distinct histopathologic features
por: Hwang, Hee Sang, et al.
Publicado: (2022) -
Bisoprolol versus celiprolol on dynamic hyperinflation, cardiopulmonary exercise and domiciliary safety in COPD: a single-centre, randomised, crossover study
por: Anderson, William, et al.
Publicado: (2023) -
Visceroptosis and the Ehlers-Danlos Syndrome
por: Kucera, Stephen, et al.
Publicado: (2017)